Stockholders’ Equity and Equity Incentive Plans (Tables)

9 Months Ended

Oct. 31, 2025

Equity [Abstract]

Schedule of Stock Option Activity Under Equity Incentive Plan

A summary of stock option activity under our equity incentive plan and related information is as follows:

	Stock Options
	Outstanding Stock Options	Weighted- Average Exercise Price	Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
	(in thousands, except share, life, and per share data)
Balance as of January 31, 2025	2,394,918	$9.02	2.6	$	187,284
Exercised	(706,307)	$2.62		$	55,601
Canceled/forfeited/expired	(5,098)	$94.87
Outstanding and exercisable as of October 31, 2025	1,683,513	$11.45	2.4	$	128,196

Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan

A summary of RSU activity under our equity incentive plan and related information is as follows:

	RSUs
	RSUs	Weighted- Average Grant Date Fair Value Per Share
Unvested as of January 31, 2025	23,870,513	$	73.48
Granted	8,157,824	$	78.45
Vested	(9,028,227)	$	76.34
Canceled/forfeited	(2,474,987)	$	72.67
Unvested as of October 31, 2025	20,525,123	$	74.34

Schedule of Stock-based Compensation Expense

The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:

	Three Months Ended October 31,				Nine Months Ended October 31,
	2025		2024		2025		2024
	(in thousands)
Cost of revenue	$	23,121	$	30,439	$	74,770	$	93,313
Research and development	70,176		89,836		213,588		254,002
Sales and marketing	61,399		80,738		192,926		242,197
General and administrative	30,586		39,982		94,266		118,858
Total stock-based compensation expense	$	185,282	$	240,995	$	575,550	$	708,370
Benefit from income taxes	(34,923)		(44,279)		(108,151)		(131,495)
Total stock-based compensation expense recorded to net income	$	150,359	$	196,716	$	467,399	$	576,875